• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

14个中国汉族MEN2A家系中RET原癌基因第10外显子种系突变的基因型-表型相关性

Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.

作者信息

Li Feng, Chen Weiying, Chen Zhenyu, Lian Bijun, Fang Xudong, Jin Hangyang, Wang Huihong, Zhao Jianqiang, Zhang Yiming, Qi Xiaoping

机构信息

Department of Oncologic and Urologic Surgery, The 903rd PLA Hospital, Hangzhou Medical College, Hangzhou, Zhejiang Province, China.

Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Enze Hospital of Hangzhou Medical College, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province, China.

出版信息

PLoS One. 2025 Sep 11;20(9):e0332136. doi: 10.1371/journal.pone.0332136. eCollection 2025.

DOI:10.1371/journal.pone.0332136
PMID:40934230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425180/
Abstract

OBJECTIVE

To investigate the genotype-phenotype correlations of multiple endocrine neoplasia type 2A (MEN2A) caused by mutations in exon 10 of the RET gene in Ethnic Han Chinese.

METHODS

A retrospective analysis was conducted on the family history and genetic characteristics of 14 independent MEN2A pedigrees, all carrying exon 10 mutations of the RET gene, from July 2003 to August 2023.

RESULTS

A total of 74 out of 133 participants carried germline mutations in exon 10 of the RET gene. The cohort included 26 males and 48 females, with nine types of mutations observed: p.C609R, p.C611F/Y, p.C618G/R/S/Y and p.C620R/S. Of these, the C618 mutation was the most prevalent (71.6%), followed by p.C611 (22.9%), p.C620 (4.1%), and p.C609 (1.4%). The penetrance rates for medullary thyroid carcinoma (MTC), pheochromocytoma, hyperparathyroidism, hirschsprung disease, and cutaneous lichen amyloidosis were 90.3%, 6.9%, 2.8%, 1.4% and 1.4%, respectively. Among the 72 patients with available clinical information, 41 (56.9%) exhibited symptoms of MTC. Comparison of the age at diagnosis, size of MTC, and the positive rate of cervical lymph node metastasis (N1) revealed significant differences between patients with symptomatic and asymptomatic MTC (all P < 0.05). There was a significant difference in the positivity rate of N1 between patients with the p.C618/C620 mutations and those with the p.C609/C611 mutations. Additionally, there was a significant difference in the initial serum calcitonin levels between N1 and N0 patients (P < 0.05).

CONCLUSION

Exon 10 mutations of the RET gene are frequently located in codon 618 and contribute to the familial MTC phenotype. To improve the recognition of MEN2A, integrating family history, testing for RET mutations, and monitoring serum calcitonin levels are essential for early diagnosis and personalised treatment.

摘要

目的

探讨汉族人群中由RET基因第10外显子突变引起的2A型多发性内分泌腺瘤病(MEN2A)的基因型与表型的相关性。

方法

对2003年7月至2023年8月期间14个独立的MEN2A家系进行回顾性分析,所有家系均携带RET基因第10外显子突变,分析其家族史和遗传特征。

结果

133名参与者中共有74人携带RET基因第10外显子的种系突变。该队列包括26名男性和48名女性,观察到9种突变类型:p.C609R、p.C611F/Y、p.C618G/R/S/Y和p.C620R/S。其中,C618突变最为常见(71.6%),其次是p.C611(22.9%)、p.C620(4.1%)和p.C609(1.4%)。甲状腺髓样癌(MTC)、嗜铬细胞瘤、甲状旁腺功能亢进、先天性巨结肠和皮肤苔藓样淀粉样变的外显率分别为90.3%、6.9%、2.8%、1.4%和1.4%。在72例有可用临床信息的患者中,41例(56.9%)表现出MTC症状。有症状和无症状MTC患者在诊断年龄、MTC大小和颈部淋巴结转移阳性率(N1)方面的比较显示出显著差异(所有P < 0.05)。p.C618/C620突变患者与p.C609/C611突变患者的N1阳性率存在显著差异。此外,N1和N0患者的初始血清降钙素水平存在显著差异(P < 0.05)。

结论

RET基因第10外显子突变常位于密码子618,与家族性MTC表型相关。为提高对MEN2A的认识,综合家族史、RET突变检测和监测血清降钙素水平对于早期诊断和个性化治疗至关重要。

相似文献

1
Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.14个中国汉族MEN2A家系中RET原癌基因第10外显子种系突变的基因型-表型相关性
PLoS One. 2025 Sep 11;20(9):e0332136. doi: 10.1371/journal.pone.0332136. eCollection 2025.
2
The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review.先天性巨结肠与2a型多发性内分泌腺瘤病之间的关联:一项系统评价。
Pediatr Surg Int. 2014 Aug;30(8):751-6. doi: 10.1007/s00383-014-3538-2. Epub 2014 Jun 28.
3
Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: A study by the French Neuroendocrine Tumor Group (GTE).携带RET原癌基因第804密码子变异的MEN 2患者甲状腺髓样癌的自然史:法国神经内分泌肿瘤研究组(GTE)的一项研究
Ann Endocrinol (Paris). 2025 Apr;86(2):101705. doi: 10.1016/j.ando.2025.101705. Epub 2025 Jan 20.
4
Multiple Endocrine Neoplasia Type 22型多发性内分泌腺瘤病
5
Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.中国甲状腺髓样癌患者及其亲属中RET基因突变的筛查
Fam Cancer. 2016 Jan;15(1):99-104. doi: 10.1007/s10689-015-9828-6.
6
[The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].[15个2A型多发性内分泌腺瘤病家系的临床模式与RET原癌基因]
Zhonghua Nei Ke Za Zhi. 2007 Jun;46(6):466-70.
7
Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants.偶然发现的MEN2A RET基因变异携带者的甲状腺髓样癌风险和死亡率
JAMA Netw Open. 2025 Jun 2;8(6):e2517937. doi: 10.1001/jamanetworkopen.2025.17937.
8
MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.与2A型多发性内分泌腺瘤相关的皮肤苔藓样淀粉样变:三个家系报告及临床、生化和分子特征的系统文献综述
Fam Cancer. 2016 Oct;15(4):625-33. doi: 10.1007/s10689-016-9892-6.
9
RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.在患有MEN2A和MEN2B的中国大陆家系中,RET原癌基因突变仅限于密码子634和918。
Clin Endocrinol (Oxf). 2007 Oct;67(4):570-6. doi: 10.1111/j.1365-2265.2007.02927.x. Epub 2007 Jun 15.
10
Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.RET原癌基因分析对2型多发性内分泌腺瘤临床管理的影响
Clinics (Sao Paulo). 2006 Feb;61(1):59-70. Epub 2006 Mar 10.

本文引用的文献

1
Accelerated MEN2A in homozygous RET carriers in the context of consanguinity.同系婚配背景下杂合 RET 突变的 MEN2A 加速发病。
Eur J Endocrinol. 2024 Mar 2;190(3):K43-K46. doi: 10.1093/ejendo/lvae025.
2
Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg mutation in an Israeli multicenter study.以色列多中心研究中一个大的家族性髓样甲状腺癌患者队列及其种系 Cys618Arg 突变的临床特征。
Front Endocrinol (Lausanne). 2023 Oct 30;14:1268193. doi: 10.3389/fendo.2023.1268193. eCollection 2023.
3
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results.
2型多发性内分泌肿瘤:迈向整合分子和生物标志物结果的基于风险的方法。
Curr Opin Oncol. 2024 Jan 1;36(1):1-12. doi: 10.1097/CCO.0000000000001009. Epub 2023 Nov 3.
4
The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.多发性内分泌肿瘤 2A 表现的变化:从对症治疗到预防医学。
J Clin Endocrinol Metab. 2023 Aug 18;108(9):e734-e742. doi: 10.1210/clinem/dgad156.
5
Simultaneous bilateral laparoscopic cortical-sparing adrenalectomy for bilateral pheochromocytomas in multiple endocrine neoplasia type 2.同期双侧腹腔镜保留皮质肾上腺切除术治疗2型多发性内分泌腺瘤病中的双侧嗜铬细胞瘤
Front Surg. 2023 Jan 10;9:1057821. doi: 10.3389/fsurg.2022.1057821. eCollection 2022.
6
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives.RET 异常致癌与 RET 抑制剂治疗:现状与未来展望。
Pharmacol Ther. 2023 Feb;242:108344. doi: 10.1016/j.pharmthera.2023.108344. Epub 2023 Jan 9.
7
Sex differences in MEN 2A penetrance and expression according to parental inheritance.根据父母遗传,MEN 2A 外显率和表现的性别差异。
Eur J Endocrinol. 2022 Feb 25;186(4):469-476. doi: 10.1530/EJE-21-1086.
8
Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤患者序贯基因检测与靶向新一代测序基因panel的成本最小化分析
Ann Med. 2021 Dec;53(1):1244-1256. doi: 10.1080/07853890.2021.1956687.
9
Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.中国通过靶向测序鉴定的种系 RET 变异体谱及相关多发性内分泌肿瘤 2 型易感性。
BMC Cancer. 2021 Apr 7;21(1):369. doi: 10.1186/s12885-021-08116-9.
10
Multiple endocrine neoplasia type 2: A review.多发性内分泌腺瘤病 2 型:综述。
Semin Cancer Biol. 2022 Feb;79:163-179. doi: 10.1016/j.semcancer.2021.03.035. Epub 2021 Apr 1.